Company: FCRX
Filing Date: 2025-02-03
Form Type: N-2/A
Source: 0001193125-25-018583
Chunk: 21

Company: Crescent Capital BDC, Inc.
Filing Date: 2025-02-03
Form: N-2/A
Chunk 21
---
 for the Company, whose report on such financial statements, together with the financial statements of the Company, are included in our Annual Report on Form 10-Kfor the fiscal year ended December 31, 2023, filed with the SEC on February 21, 2024, and are incorporated by reference herein. The Financial Highlights for the years ended December 31, 2018, December 31, 2017 and December 31, 2016 and the period from February 5, 2015 to December 31, 2015 contained under “ Part I. Item 1. Financial Statements—Notes to Consolidated Financial Statements —Note 12. Financial Highlights” in our Annual Report on Form 10-Kfor the fiscal year ended December 31, 2018, filed with the SEC on March 22, 2019 are incorporated herein by reference.No other portions of our Annual Report on Form 10-Kfor the fiscal year ended December 31, 2018 are incorporated by reference herein. The financial highlights table is intended to help you understand the Company’s financial performance. 14 RISK FACTORS You should carefully consider the risk factors described below, and in the section titled “Risk Factors” in the applicable prospectus supplement and any related free writing prospectus, and the risks discussed in the section titled “Item 1A. Risk Factors” in our Annual Report on Form 10-K,which is incorporated by reference herein, and any subsequent filings we have made with the SEC that are incorporated by reference into this prospectus or any prospectus supplement, together with all of the other information included in this prospectus, the accompanying prospectus supplement and any documents incorporated by reference herein, including our consolidated financial statements and the related notes thereto, before you decide whether to make an investment in our securities. The risks set out below and described in such documents are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results. If any of the following events occur, our business, financial condition and results of operations could be materially adversely affected. In such case, the net asset value of our common stock and the trading price, if any, of our securities could decline, and you may lose all or part of your investment. Investors in offerings of our common stock will likely incur immediate dilution upon the closing of such offering. We generally expect the public offering price of